The diabetes drugs containing saxagliptin and alogliptin may be linked to heart failure and other physical complications including shortness of breath, tiredness, and weakness. This is especially a risk for patients with heart or kidney disease, U.S. health officials warned last month. Drugs containing these ingredients are Onglyza, Kombiglyza XR, Nesina, Kazano, and Oseni, the […]